Intelligent Bio Solutions announced it has secured 8 new customers across various locations throughout Australia, which collectively employ over 10,000 individuals, within just two months of launching its Intelligent Fingerprinting Drug Screening System in Australia. “Our rapidly expanding customer footprint across the region is a testament to our innovative technology and the quality and value of our drug screening solution,” said Harry Simeonidis, President and Chief Executive Officer of Intelligent Bio Solutions. “We remain focused on advancing this growth and delivering a convenient and dignified alternative that continues to meet the screening needs of businesses across Australia.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on INBS:
- Intelligent Bio Solutions files to sell Class A, Class B units, no amount given
- Intelligent Bio Solutions signs South American distribution agreement
- Intelligent Bio Solutions Signs South American Distribution Agreement with TSCOM for Fingerprint Drug Screening System and Secures First Order
- Intelligent Bio Solutions Receives Guidance from U.S. FDA on a Regulatory Pathway for Expansion into the United States for its Intelligent Fingerprinting Drug Screening Cartridge
- Intelligent Bio Solutions to submit 510(k) pre-market notification to FDA